Company: HBAN
Filing Date: 2025-11-13
Form Type: S-4
Source: 0001140361-25-041757
Chunk: 190

Company: HUNTINGTON BANCSHARES INC /MD/
Filing Date: 2025-11-13
Form: S-4
Chunk 190
---
 adverse recommendation change or Huntington adverse recommendation change, respectively, in case defined below) by communicating to its shareholders its recommendation (and including such recommendation in this joint proxy statement/prospectus) that they approve, in the case of Cadence, the merger agreement and the transactions contemplated thereby (the “Cadence board recommendation”), and in the case of Huntington, the issuance of Huntington common stock in connection with the merger (the “Huntington board recommendation”) and will not make a Cadence adverse recommendation change or a Huntington adverse recommendation change,**

<div align='center'>113</div>

#### TABLE OF CONTENTS
respectively, except as described below. Each of Cadence and the Huntington Parties will engage a proxy solicitor reasonably acceptable to the other party to assist in the solicitation of proxies from shareholders relating to the requisite Cadence vote or the requisite Huntington vote, as applicable. However, subject to certain termination rights in favor of the other party as described in the sections entitled “The Merger Agreement—Termination of the Merger Agreement” and “The Merger Agreement—Effect of Termination,” if the Cadence board of directors or the Huntington board of directors, after receiving the advice of its outside counsel and, with respect to financial matters, its financial advisors, determines in good faith (x) that an acquisition proposal constitutes a superior proposal and that it would more likely than not result in a violation of its fiduciary duties under applicable law to continue to recommend in Cadence’s case the merger agreement and the merger and in Huntington’s case the issuance of Huntington common stock in connection with the merger or (y) in response to an intervening event that it would more likely than not result in a violation of its fiduciary duties under applicable law to continue to recommend, in Cadence’s case the merger agreement and the merger and in Huntington’s case the issuance of Huntington common stock in connection with the merger, then, prior to the receipt of the requisite Cadence vote or the requisite Huntington vote, as applicable, in submitting the merger agreement and the merger to its shareholders, the board of directors of Cadence or the board of directors of Huntington, as applicable, may withhold or withdraw or modify or qualify in a manner adverse to the Huntington Parties or Cadence, as applicable, the Cadence board recommendation or the Huntington board recommendation, as applicable, or may submit the merger agreement and the merger to its shareholders without recommendation (each, a “Cadence adverse recommendation change” or a “Huntington adverse recommendation change,” respectively)